Possible roles for frequent salivary antiepileptic drug monitoring in the management of epilepsy
Authors:
- M.J. EadieMEM.J. Eadie
- 1 July 1990
- journal article
- research article
- Published by Elsevier in Epilepsy Research
- Vol. 6 (2) , 146-154
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Phenytoin Levels in Catamenial EpilepsyEpilepsia, 1988
- Fallacious Results from Measuring Salivary Carbamazepine ConcentrationsTherapeutic Drug Monitoring, 1985
- Effects of intravenous progesterone infusions on the epileptic discharge frequency in women with partial epilepsyActa Neurologica Scandinavica, 1984
- The Place of Saliva in Antiepileptic Drug MonitoringTherapeutic Drug Monitoring, 1984
- Progesterone and estradiol in the saliva and plasma during the menstrual cycleAmerican Journal of Obstetrics and Gynecology, 1983
- Salivary concentrations and plasma protein binding of carbamazepine and carbamazepine 10,11‐epoxide in epileptic patients.British Journal of Clinical Pharmacology, 1981
- Antiepileptic DrugsClinical Pharmacokinetics, 1979
- Therapeutic Drug Monitoring in SalivaClinical Pharmacokinetics, 1978
- Disposition of valproic acid in manEuropean Journal of Clinical Pharmacology, 1977
- EPILEPSY AND MENSTRUATIONThe Lancet, 1956